Trial Profile
A retrospective, open label, single arm trial of nimotuzumab with induction of chemoradiation in patients with advanced head and neck cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Nimotuzumab (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 08 Dec 2015 New trial record